Search

everythinglearnresearchcommunity

for

Search:↓

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Loss of Dnmt3a and Dnmt3b increases aggressive skin tumors by affecting PPAR-γ.

The study suggests that complement activation, not immunoglobulins, may be important in erythema nodosum leprosum.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Special immune cells called Treg cells are important for maintaining and regenerating hair by activating a specific growth signal in hair stem cells.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

A specific type of immune cells, called CD301b-expressing macrophages, are crucial for skin repair processes.

Controlling Tslp can improve health in AEC syndrome patients.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

CD8+ virtual memory T cells may cause hair loss in alopecia areata.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

γδ T cells help with hair growth during wound healing in mice.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

A deletion in the CDH3 gene causes a rare disorder with short hair and vision loss.

Overexpressing ATF3 in mice's epithelial cells may lead to oral cancer.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

Anti-Desmocollin 3 antibodies can cause atypical pemphigus symptoms.

Bone marrow-derived cells can lead to skin inflammation and tumors in mice.

Low CD4 counts in HIV patients are linked to more skin disorders.

Lower SMAD2/3 activation predicts more severe skin cancer.

Lack of Vitamin D receptor changes skin structure and increases certain immune cells in the skin.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.